Understanding the Tip:
The role of FTIR in identity and integrity verification:
Fourier-transform infrared spectroscopy (FTIR) is a powerful, non-destructive analytical tool for monitoring chemical identity based on molecular vibrations. In pharmaceutical stability studies, FTIR helps confirm the presence of API and excipients, detect polymorphic transitions, and identify early degradation signals. Incorporating FTIR into stability testing ensures your formulation maintains its intended structure and composition throughout its shelf life.
Consequences of neglecting identity verification during stability:
Failing to assess formulation identity using orthogonal methods like FTIR can result in:
- Unnoticed polymorphic or hydration state changes
- Misinterpretation of degradation caused by chemical transformation
- Regulatory queries about formulation consistency
- Delayed investigations or potential recalls due to unexpected product behavior
Using FTIR strengthens your analytical portfolio and provides early-warning insights into product changes under stress or storage.
Regulatory and Technical Context:
ICH and WHO requirements for identity and stability verification:
ICH Q1A(R2) and WHO TRS 1010 encourage comprehensive analytical approaches to evaluate product quality over time. Although FTIR is not always mandatory, it is considered a valuable orthogonal method in stability studies—especially for APIs prone to polymorphic conversion or susceptible to moisture uptake. In CTD Module 3.2.P.5 and 3.2.P.8.3, FTIR results help justify the retention of physical and chemical identity throughout the declared shelf life.
Expectations
Inspectors may review whether your analytical strategy includes adequate verification of formulation integrity across time points. FTIR spectra comparison at initial and final time points demonstrates that no significant structural transformation has occurred, and may support impurity justification or equivalency claims following manufacturing or packaging changes.
Best Practices and Implementation:
Develop and validate FTIR methods specific to your formulation:
Customize FTIR methods to monitor:
- API fingerprint regions (e.g., 1600–1800 cm-1)
- Excipient-specific bands (e.g., lactose, mannitol, PVP)
- Key indicators of degradation (e.g., carbonyl peak shifts)
Validate methods per ICH Q2(R2) guidelines for specificity, precision, and detection of subtle changes. Create a reference spectral library for baseline comparison throughout the study.
Integrate FTIR into your stability testing workflow:
At defined time points (e.g., 0M, 3M, 6M, 12M), compare test samples to initial spectra. Assess:
- Shifts or disappearance of characteristic peaks
- Formation of new bands indicating degradation
- Changes in polymorph-specific absorption regions
Use software-based spectral matching and overlay visualization to detect and document changes. Incorporate these comparisons into your stability summary reports.
Document spectral trends and align with other analytical findings:
Correlate FTIR observations with:
- Assay or impurity profile data
- XRPD or DSC for physical changes
- Appearance and dissolution test results
Include a summary of FTIR findings in your regulatory submissions, especially for complex products such as fixed-dose combinations, oral solids with known polymorph risks, or inhalation powders.
FTIR is more than just a confirmation technique—it’s a strategic component of modern stability science, providing precise molecular insights that support formulation consistency, regulatory compliance, and patient safety.